Titan Bio-Tech share news, announcements and annual reports
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹352.00.
29 Oct: open ₹356.15, high ₹365.00, low ₹346.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,862 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 10.25
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 67,921
Titan Bio-Tech share news and announcements
605 announcements, routine notices left out, newest first. Page 4 of 13.
Oct 2022
1 Oct · Meeting
1 Oct · Meeting
Aug 2022
31 Aug · Reg. 34 (1) Annual Report.
26 Aug · Management
26 Aug · Meeting
26 Aug · Meeting
10 Aug · Results
2 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
Jul 2022
18 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
May 2022
30 May · Results
19 May · Board meeting
Meeting on 30 May 2022: final dividend and audited results
Apr 2022
13 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Mar 2022
Feb 2022
17 Feb · Announcement Under Regulation 30 Relating To Dilution In Shareholding In Subsidiary Company Namely Peptech Biosciences Limited.
Jan 2022
31 Jan · Board meeting
Meeting on 9 Feb 2022: quarterly results13 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....13 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 3 3 0
Nov 2021
12 Nov · Results
1 Nov · Board meeting
Meeting on 12 Nov 2021: quarterly results
Oct 2021
18 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....9 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
25 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2021
25 Aug · Reg. 34 (1) Annual Report
17 Aug · Board meeting
Meeting on 25 Aug 2021: annual general meeting10 Aug · Management
10 Aug · Results
Jul 2021
30 Jul · Board meeting
Meeting on 10 Aug 2021: quarterly results27 Jul · Management
8 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1 0 1 07 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....